These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10783183)
1. Effects of substance dependence on outcomes of patients in a randomized trial of two case management models. Havassy BE; Shopshire MS; Quigley LA Psychiatr Serv; 2000 May; 51(5):639-44. PubMed ID: 10783183 [TBL] [Abstract][Full Text] [Related]
2. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Havassy BE; Arns PG Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229 [TBL] [Abstract][Full Text] [Related]
3. Outcome of planned discharge from case management: a 3 year retrospective study. Backus L; Weinkove J; Lucas M; Jespersen S Australas Psychiatry; 2008 Feb; 16(1):33-8. PubMed ID: 17957526 [TBL] [Abstract][Full Text] [Related]
4. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders. Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221 [TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472 [TBL] [Abstract][Full Text] [Related]
7. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris]. Goeb JL; Coste J; Bigot T; Ferrand I Encephale; 2000; 26(6):11-20. PubMed ID: 11217533 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people. Hides L; Carroll S; Catania L; Cotton SM; Baker A; Scaffidi A; Lubman DI J Affect Disord; 2010 Feb; 121(1-2):169-74. PubMed ID: 19604584 [TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Brunette MF; Noordsy DL; Xie H; Drake RE Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527 [TBL] [Abstract][Full Text] [Related]
11. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services. Ogloff JR; Lemphers A; Dwyer C Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839 [TBL] [Abstract][Full Text] [Related]
12. Remission of psychiatric symptoms among drug misusers after drug dependence treatment. Gossop M; Marsden J; Stewart D J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706 [TBL] [Abstract][Full Text] [Related]
13. Psychiatric hospital outcomes of dual diagnosis patients under managed care. Leon SC; Lyons JS; Christopher NJ; Miller SI Am J Addict; 1998; 7(1):81-6. PubMed ID: 9522010 [TBL] [Abstract][Full Text] [Related]
14. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care. Stahler GJ; Mennis J; Cotlar R; Baron DA Am J Psychiatry; 2009 Nov; 166(11):1258-68. PubMed ID: 19797433 [TBL] [Abstract][Full Text] [Related]
15. [Dual diagnosis in psychoactive substance abusing or dependent persons]. Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766 [TBL] [Abstract][Full Text] [Related]
17. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness. Jerrell JM; Ridgely MS J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic limit setting in an assertive community treatment program. Neale MS; Rosenheck RA Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826 [TBL] [Abstract][Full Text] [Related]
19. Transition to low intensity case management in a VA Assertive Community Treatment model program. Rosenheck RA; Neale MS; Mohamed S Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987 [TBL] [Abstract][Full Text] [Related]
20. The MICA Case Conference Program at Tewksbury Hospital, Mass.: an integrated treatment model. Clodfelter RC; Albanese MJ; Baker G; Domoto K; Gui AL; Khantzian EJ Am J Addict; 2003; 12(5):448-54. PubMed ID: 14660158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]